Bayer Shares Outstanding 2006-2020 | BAYRY

Bayer shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Bayer shares outstanding for the quarter ending June 30, 2020 were 3.929B, a 0.06% increase year-over-year.
  • Bayer 2019 shares outstanding were 3.927B, a 4.35% increase from 2018.
  • Bayer 2018 shares outstanding were 3.763B, a 7.87% increase from 2017.
  • Bayer 2017 shares outstanding were 3.488B, a 4.76% increase from 2016.
Bayer Annual Shares Outstanding
(Millions of Shares)
2019 3,927
2018 3,763
2017 3,488
2016 3,330
2015 3,308
2014 3,308
2013 3,308
2012 3,308
2011 3,304
2010 3,315
2009 3,198
2008 3,106
2007 3,230
2006 3,032
2005 2,913
Bayer Quarterly Shares Outstanding
(Millions of Shares)
2020-06-30 3,929
2020-03-31 3,918
2019-12-31 3,927
2019-09-30 3,930
2019-06-30 3,927
2019-03-31 3,921
2018-12-31 3,763
2018-09-30 3,921
2018-06-30 3,663
2018-03-31 3,490
2017-12-31 3,488
2017-09-30 3,490
2017-06-30 3,488
2017-03-31 3,308
2016-12-31 3,330
2016-09-30 3,320
2016-06-30 3,305
2016-03-31 3,302
2015-12-31 3,308
2015-09-30 3,302
2015-06-30 3,314
2015-03-31 3,299
2014-12-31 3,308
2014-09-30 3,304
2014-06-30 3,315
2014-03-31 3,309
2013-12-31 3,308
2013-09-30 3,294
2013-06-30 3,298
2013-03-31 3,314
2012-12-31 3,308
2012-09-30 3,300
2012-06-30 3,293
2012-03-31 3,307
2011-12-31 3,308
2011-09-30 3,308
2011-06-30 3,308
2011-03-31 3,296
2010-12-31 2,417
2010-09-30 3,308
2010-06-30 3,308
2010-03-31 3,308
2009-12-31 3,400
2009-09-30 3,308
2009-06-30 3,140
2009-03-31 3,091
2008-12-31 3,298
2008-09-30 2,995
2008-06-30 3,184
2008-03-31 3,175
2007-12-31
2007-09-30 3,219
2007-06-30 3,181
2007-03-31 3,266
2006-12-31
2006-09-30 3,048
2006-06-30 3,013
2006-03-31 2,912
2005-12-31
2005-09-30 2,918
2005-06-30 2,943
2005-03-31 2,927
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $58.490B $48.230B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $387.183B 18.45
Roche Holding AG (RHHBY) Switzerland $297.019B 0.00
Merck (MRK) United States $207.145B 14.78
Pfizer (PFE) United States $200.992B 12.56
Novartis AG (NVS) Switzerland $199.208B 15.49
Novo Nordisk (NVO) Denmark $165.354B 26.90
AbbVie (ABBV) United States $153.346B 9.34
AstraZeneca (AZN) United Kingdom $144.629B 28.12
Eli Lilly (LLY) United States $139.893B 21.35
Sanofi (SNY) $126.459B 15.03
GlaxoSmithKline (GSK) United Kingdom $93.894B 12.31
H Lundbeck (HLUYY) Denmark $6.527B 11.34
Innoviva (INVA) United States $1.047B 5.01